In Q4'25, SG&A Expenses for CVNA reached $627M, marking the highest point in the observed period and reflecting ongoing cost pressures in administrative and sales functions, while R&D Expenses remained at no data across all quarters. This latest data point indicates a quarterly increase of $32M from Q3'25, underscoring a persistent upward trajectory in operating costs. From Q1'23 to Q4'25, SG&A Expenses exhibited a steady upward trend, rising from $472M to $627M with minor fluctuations—such as a dip to $433M in Q3'23—before consistent growth averaging about 7% per quarter in 2025, potentially signaling expansion or inflationary impacts. R&D Expenses showed no data throughout the period, suggesting this category may not be separately reported or applicable in CVNA's financial structure. Overall, the stacked bar chart highlights SG&A as the dominant component of operating expenses, with total costs climbing approximately 33% over the three-year span.